SHIRLEY SMEARMAN CHARETTE: Open Payments
NPI 1255327037 · DOVER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 27 payments from 11 companies in 2025. Trend: 2023 $882 · 2024 $1,039 · 2025 $651
Food & beverage: $651
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $319 |
| Lilly USA, LLC | 2 | $76 |
| ABBVIE INC. | 3 | $63 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Astellas Pharma US Inc | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Abbott Laboratories | 1 | $16 |
Products named: AIRSUPRA, BREZTRI, VRAYLAR, ZEPBOUND, GVOKE HYPOPEN, FARXIGA, TRELEGY ELLIPTA, Veozah.
Industry payments across OH — which companies pay providers there.
